Suneel Mundle

67 posts

Suneel Mundle banner
Suneel Mundle

Suneel Mundle

@MundleSuneel

Experienced Biopharmaceutical Professional

Katılım Ağustos 2020
36 Takip Edilen59 Takipçiler
Suneel Mundle retweetledi
Simon C
Simon C@scserendipity1·
@neerajaiims @ASCO @OncoAlert @PCF_Science @urotoday @CaPsurvivorship @MundleSuneel @MAWJNJ @AzadOncology @montypal @DrChoueiri @TiansterZhang @PGrivasMDPhD @Huntsman_GU Great work Neeraj. Important data in many ways. PSA is very important to our patients and hopefully this rapid and deep response provides reassurance to them and their families. And it allows us an easy way of potentially identifying patients for de-escalation and escalation..
English
0
2
4
0
Suneel Mundle
Suneel Mundle@MundleSuneel·
Deep Prostate-specific Antigen Response following Addition of Apalutamide to Ongoing Androgen Deprivation Therapy and Long-term Clinical Benefit in SPARTAN - ScienceDirect sciencedirect.com/science/articl…
English
1
8
15
0
Suneel Mundle retweetledi
Arun Azad
Arun Azad@AzadOncology·
Pleased to present analysis of rash in SPARTAN and TITAN studies @ #EMUC21. Apalutamide rash is: 🔹Seen in 1/4 pts, typically early 🔹Transient, responds to early steroids, antihistamines 🔹Not A/W Rx outcome 🌟Apalutamide remains a safe and effective Rx for #ProstateCancer🌟
Arun Azad tweet media
English
2
32
86
0
Suneel Mundle retweetledi
Mark Wildgust (he/him)
Mark Wildgust (he/him)@MAWildgust·
Important paper by @neerajaiims @scserendipity1 @amerseburger and other authors showing you can improve OS and rPFS with no increase in fatigue and maintaining QOL. @JUrology
Journal of Urology@JUrology

Open Access Article from the October Issue: Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study bit.ly/3kxrf5u

English
0
14
18
0
Suneel Mundle
Suneel Mundle@MundleSuneel·
All very pertinent questions
David Olmos@Dolmos77

@cdanicas @neerajaiims @OncoAlert @Ecastromarcos I admit I am amazed, It is clearly very good news for mCRPC pts. Looking forward to see the data. Any potential differences in HRR+ and HRR negative subgroups? Other combinations has shown rPFS but not OS, would this show OS? In BRCAmut open question: combination VS sequential

Català
0
0
2
0
David Olmos
David Olmos@Dolmos77·
@cdanicas @neerajaiims @OncoAlert @Ecastromarcos I admit I am amazed, It is clearly very good news for mCRPC pts. Looking forward to see the data. Any potential differences in HRR+ and HRR negative subgroups? Other combinations has shown rPFS but not OS, would this show OS? In BRCAmut open question: combination VS sequential
English
2
0
7
0
Suneel Mundle retweetledi
Simon C
Simon C@scserendipity1·
And I believe lower tox than Abi. Look at Lattitude. Mature data, broad categories. We need to get these drugs to patients and drop ADT for those who respond well. Docetaxel isn’t relevant for most patients/doctors. It should be but it isn’t. A wise man told me that…
Mark Wildgust (he/him)@MAWildgust

@_ShankarSiva @DrChoueiri @myESMO @TiansterZhang @urotoday @neerajaiims @montypal @DrRanaMcKay @PGrivasMDPhD @scserendipity1 @AzadOncology @DrMLChua @alison_tree @Prof_IanD @Prof_Nick_James Apa + ADT improves OS in both de novo diagnosed and those with prior localized treatment regardless of volume/risk as presented at #EAU2020 #mycompany

English
1
2
7
0
Suneel Mundle retweetledi
Arun Azad
Arun Azad@AzadOncology·
Highly impressive data. PSA remains an excellent (and cheap) early on-treatment biomarker for stratifying clinical outcomes in mHSPC and MO CRPC. Very important for both pts and physicians alike. @neerajaiims @MundleSuneel @scserendipity1 @amerseburger @DrMLChua
Neeraj Agarwal, MD, FASCO@neerajaiims

@AmerUrological #AUA2021 Podium abstract PD34-11👉In men enrolled on TITAN & SPARTAN trials: PSA responses (PSA90% & PSA≤0.2ng/ml) were rapid and associated with striking improvement in survival outcomes (rPFS/MFS, OS)👇bit.ly/2VyRhvs @OncoAlert Greats news for our pts!

English
4
9
39
0

Keşfet

@CCR_AACR @neerajaiims @EAntonarakis @geoff_oxnard @OncoAlert @PCF_Science @Decipher_VCYT @ravikanesvaran